This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Sertindole

Authoring team

  • a phenylindole derivative
  • binds to striatal D2 receptors
  • sertindole is effective against positive symptoms of schizophrenia while not causing anticholinergic or extrapyrimidal side effects

Cardiac side effects:

  • sertindole causes a prolonged QT interval in 1-2% of patients - therefore treatment with sertindole may precipitate cardiac arrythmias
  • it is mandatory for an ECG to be performed before and during treatment
  • sertindole may interact with antihistamines such as terfenidine and astemizole, as well as antiarrhythmics and tricyclic antidepressants
  • sertindole is contraindicated if there is a low serum potassium

The availability of sertindole was voluntarily suspended by the manufacturers in December of 1998. This was following reports of cardiac arrhythmias and sudden death associated with the use of sertindole.

Reference:

  • BJGP (1999), 49 (446), 745-9

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.